FinancialContent is the trusted provider of stock market information to the media industry.
More NewsRead More
Provectus Biopharmaceuticals’ Poster Presentation Displayed on Phase 3 Study of PV-10 at 5th European Post-Chicago Melanoma / Skin Cancer Meeting
June 25, 2015
Provectus Biopharmaceuticals Announces Abstract Available on PV-10 for Chemoablation of Liver Cancers at ESMO 17th World Congress on Gastrointestinal Cancer
June 24, 2015
Provectus Biopharmaceuticals Retains PharmaHEALTHLabs to Facilitate Investigator Advisory Board Meeting During 11Th Brazilian Melanoma Conference
June 22, 2015
Provectus Biopharmaceuticals, Inc. Announces Pricing of Public Offering to Raise $13.1 Million
June 19, 2015
Provectus Biopharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants
June 18, 2015
Abstract on Provectus Biopharmaceuticals’ PV-10 in Colon Cancer Models Published by Society of Surgical Oncology
June 16, 2015
Provectus Biopharmaceuticals to Present at 2015 BIO International Convention in Philadelphia
June 11, 2015
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here